Gisborne Herald
  • Gisborne Herald Home
  • Latest news
  • Business
  • Lifestyle
  • Sport

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • On The Up
  • Business
  • Lifestyle
  • Sport

Locations

  • Gisborne
  • Bay of Plenty
  • Hawke's Bay

Media

  • Today's Paper - E-Editions
  • Photo sales
  • Classifieds

Weather

  • Gisborne

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In

Advertisement
Advertise with NZME.
Premium
Home / Gisborne Herald / Business

Rua loss expected

Gisborne Herald
17 Mar, 2023 08:26 PMQuick Read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save
    Share this article

    Reminder, this is a Premium article and requires a subscription to read.

TENDING PLANTS: Rua Bioscience's plant health specialist Hamish Harris, inside the company's purpose-built cultivation centre in Ruatorea. Rua Bioscience picture

TENDING PLANTS: Rua Bioscience's plant health specialist Hamish Harris, inside the company's purpose-built cultivation centre in Ruatorea. Rua Bioscience picture

Tairawhiti-based medicinal cannabis company Rua Bioscience has announced a $6.17 million loss but expects to have cannabis products available by next year.

Rua Bioscience today announced its annual financial results for the 12 months ended June 30 2021 (FY21).

The company, which listed on the New Zealand Stock Exchange in October 2020, recorded a loss before tax of $6.17m.

The result was in line with the board's expectations for the year end and sees Rua further continue to roll out its strategy to deliver revenue through export sales of pharmaceutical-grade dried cannabis flower to Germany and manufacture the company's first products for New Zealand patients.

“As a company we continue to focus on the development of our product portfolio and the associated systems and processes in both our cultivation and manufacturing operations,” company chief financial officer Hamish White said.

Advertisement
Advertise with NZME.

“The IPO (initial public offering) in October 2020 was a significant milestone for the company and has provided the funding to continue our momentum as we begin to transition into commercialisation in (financial year) 2022,” he said.

The company achieved several key milestones in its strategy during the period, including a successful, oversubscribed IPO. The company was listed on the NZX in October 2020, raising its targeted $20 million.

Rua deployed funds raised from the IPO across strategic priority areas that underpin achieving initial sales and revenue.

Advertisement
Advertise with NZME.

A company statement said it anticipated having product available for New Zealand patients as a prescription-only medicine in 2022, once it had obtained GMP certification, completed the New Medicines Application process and Ministry of Health's Quality Standard assessment, which are required for all new products.

Of the company's 30 staff as at balance date, 15 have whanau connections or whakapapa to Te Tairawhiti. These staff work at all levels of the organisation.

Save
    Share this article

    Reminder, this is a Premium article and requires a subscription to read.

Latest from Business

Gisborne Herald

'Extremely difficult': 45 jobs will be lost in Columbine Industries closure

Business

House prices down in most regions in year to March

Gisborne Herald

On The Up: How a couple from Auckland now serve a small East Coast settlement


Sponsored

Kiss cams and passion cohorts: how brands get famous in culture

Advertisement
Advertise with NZME.

Latest from Business

'Extremely difficult': 45 jobs will be lost in Columbine Industries closure
Gisborne Herald

'Extremely difficult': 45 jobs will be lost in Columbine Industries closure

Columbine Industries in Disraeli St will close in about two months, with 45 roles ending.

28 May 05:00 PM
House prices down in most regions in year to March
Business

House prices down in most regions in year to March

14 Apr 10:09 PM
On The Up: How a couple from Auckland now serve a small East Coast settlement
Gisborne Herald

On The Up: How a couple from Auckland now serve a small East Coast settlement

11 Apr 05:00 PM


Kiss cams and passion cohorts: how brands get famous in culture
Sponsored

Kiss cams and passion cohorts: how brands get famous in culture

01 Aug 12:26 AM
NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • Manage your print subscription
  • Manage your digital subscription
  • Subscribe to Herald Premium
  • Subscribe to the Gisborne Herald
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • Gisborne Herald
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Bay of Plenty Times
  • Rotorua Daily Post
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven Car Guide
  • iHeart Radio
  • Restaurant Hub
NZME
  • NZME Events
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Photo sales
  • © Copyright 2025 NZME Publishing Limited
TOP